* co-first author; ¶ co-corresponding author
2021 (3)
Progress in methodologies and quality-control strategies in protein cross-linking mass spectrometry
Kumar Y, Zhao Q, Gupta S, Xiong D, and Yu H. Proteomics 2021 2100145.
Kumar Y, Zhao Q, Gupta S, Xiong D, and Yu H. Proteomics 2021 2100145.
A 3D structural SARS-CoV-2–human interactome to explore genetic and drug perturbations
Wierbowski SD, Liang S, Liui Y, Chen Y, Gupta S, Andre NM, Lipkin SM, Whittaker GR, Yu H. Nature Methods 2021 December 18, 1477–1488. .
First published on bioRxiv 2020 (DOI:10.1101/2020.10.13.308676)
Wierbowski SD, Liang S, Liui Y, Chen Y, Gupta S, Andre NM, Lipkin SM, Whittaker GR, Yu H. Nature Methods 2021 December 18, 1477–1488. .
First published on bioRxiv 2020 (DOI:10.1101/2020.10.13.308676)
In-depth and 3-Dimensional Exploration of the Budding Yeast Phosphoproteome
Lanz MC, Kumar Y, Gupta S, Sanford E, Faça V, Vega S, Joiner A, Fromme C, Yu H, and Smolka M. EMBO Reports 2021 22:e51121.
Lanz MC, Kumar Y, Gupta S, Sanford E, Faça V, Vega S, Joiner A, Fromme C, Yu H, and Smolka M. EMBO Reports 2021 22:e51121.
2020 (1)
Maximized quantitative phosphoproteomics allows high confidence dissection of the DNA damage signaling network
Faca VM, Sanford EJ, Tieu J, Comstock W, Gupta S, Marshall S, Yu H, and Smolka MB. Sci Rep 2020 10(1):18056.
Faca VM, Sanford EJ, Tieu J, Comstock W, Gupta S, Marshall S, Yu H, and Smolka MB. Sci Rep 2020 10(1):18056.